3 employees
Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.
2020
Lipidio Pharmaceuticals raised undisclosed on March 3, 2020
Investors: Alethea Capital Management LLC and 3E Bioventures Capital